Sampling Site Has a Critical Impact on Physiologically Based Pharmacokinetic Modeling.

作者: Weize Huang , Nina Isoherranen

DOI: 10.1124/JPET.119.262154

关键词:

摘要: It has been shown that arterial (central) and venous (peripheral) plasma drug concentrations can be very different. While pharmacokinetic studies typically measure from the peripheral vein such as arm vein, physiologically based (PBPK) models generally output simulated central compartment represents right atrium, a merge of superior inferior vena cava. In this study, forearm sampling site model was developed verified using nicotine, ketamine, lidocaine, fentanyl drugs. This allows meaningfully compared with observed data vein. The generalized effect PBPK on simulation investigated. Drugs metabolites large volumes distribution showed considerable concentration discrepancy between after intravenous or oral administration, resulting in significant differences values for Cmax time taken to reach (tmax) addition, metabolite profile an unexpected not Using compound, we show wrong lead biased evaluation subsequent erroneous parameter optimization. Such error parameters along discrepant could dramatically mislead prediction unstudied clinical scenarios, affecting assessment safety efficacy. Overall, study shows publications should specify sites match them those employed studies. SIGNIFICANCE STATEMENT Our (right atrium) during development gives rise parameterization when are collected clinically predictions concentration-time profiles scenarios. To address error, novel simulate applied different dosing

参考文章(50)
B. Tuk, M. Danhof, J. W. Mandema, The Impact of Arteriovenous Concentration Differences on Pharmacodynamic Parameter Estimates Journal of Pharmacokinetics and Biopharmaceutics. ,vol. 25, pp. 39- 62 ,(1997) , 10.1023/A:1025767710234
Maria Pitsiu, Jean-Michel Gries, Neal Benowitz, Steven G. Gourlay, Davide Verotta, Modeling Nicotine Arterial–Venous Differences to Predict Arterial Concentrations and Input Based on Venous Measurements: Application to Smokeless Tobacco and Nicotine Gum Journal of Pharmacokinetics and Pharmacodynamics. ,vol. 29, pp. 383- 402 ,(2002) , 10.1023/A:1020957208071
Helen Musther, Katherine L. Gill, Manoranjenni Chetty, Amin Rostami-Hodjegan, Malcolm Rowland, Masoud Jamei, Are Physiologically Based Pharmacokinetic Models Reporting the Right C(max)? Central Venous Versus Peripheral Sampling Site. Aaps Journal. ,vol. 17, pp. 1268- 1279 ,(2015) , 10.1208/S12248-015-9796-7
Hannah M. Jones, Kapil Mayawala, Patrick Poulin, Dose Selection Based on Physiologically Based Pharmacokinetic (PBPK) Approaches The AAPS Journal. ,vol. 15, pp. 377- 387 ,(2013) , 10.1208/S12248-012-9446-2
Karen Rowland Yeo, Mohsen Aarabi, Masoud Jamei, Amin Rostami-Hodjegan, Modeling and predicting drug pharmacokinetics in patients with renal impairment Expert Review of Clinical Pharmacology. ,vol. 4, pp. 261- 274 ,(2011) , 10.1586/ECP.10.143
Mona Darwish, Mary Kirby, Philmore Robertson, Edward Hellriegel, John G Jiang, Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics. Clinical Pharmacokinectics. ,vol. 45, pp. 843- 850 ,(2006) , 10.2165/00003088-200645080-00006
Kristin Moksnes, Olav M. Fredheim, Pål Klepstad, Stein Kaasa, Anders Angelsen, Turid Nilsen, Ola Dale, Early pharmacokinetics of nasal fentanyl: is there a significant arterio-venous difference? European Journal of Clinical Pharmacology. ,vol. 64, pp. 497- 502 ,(2008) , 10.1007/S00228-007-0444-8